However, controversy still remained because it had been reported that CD133 expression is not restricted to intestinal stem or cancer-initiating cells, and both CD133+ and CD133- metastatic colon cancer cells could initiate tumors[40]. The gene discussed is PROM1; the disease is colonic neoplasm.